Fut, nem toborozFázis nélkül
Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
A legfontosabb adatok
- Ki végzi
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Hol
- Bulgária, Görögország és Törökország7 helyszín, 3 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 164 fő vett részt
- Kezdés
- 2023. szept. 15.
- Várható befejezés
- 2028. szept. 30.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Ankura™ AAA Stent Graft System; Ankura™ Cuff Stent Graft System; Ankura™ AUI Stent Graft System
- A regiszteradat frissítve
- 2026. május 26.
Ki vehet részt
- Életkor
- 18 év – 85 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Patient diagnosed with Abdominal Aortic Aneurysm (AAA), who needs endovascular aortic repair
- Patient's anatomy suits Ankura™ AAA and Cuff Stent Graft Systems, or AUI Stent Graft IFU requirements, which indicated by the following:; Adequate iliac/femoral access vessel that is compatible with the required delivery system; Non-aneurysmal proximal aortic neck length ≥15mm; Non-aneurysmal proximal aortic neck diameter of 18-32mm; Proximal aortic neck angulation ≤ 60°; Distal iliac artery anchorage zone ≥15mm; Distal iliac artery diameter of i. 8-22 mm (for Ankura™ AAA and Cuff Stent Graft Systems), OR ii. 10-16 mm (for Ankura™ AUI Stent Graft System); Morphology suitable for endovascular repair
- Patient could understand the purpose of the clinical trial, agrees to comply with the requirements of the study including the 3-year follow-up, and signed the patient informed consent, will participate in the study
Ki nem vehet részt
- Patient with concomitant thoracic aortic or thoraco-abdominal aneurysms;
- Subject must not be participating in another study for an investigational drug and/or device that may clinically interfere with this study's endpoints
- Patient with any contraindications mentioned in the Ankura™ AAA and Cuff Stent Graft Systems, or in Ankura™ AUI Stent Graft system IFU:; Patient with acute systemic infection; Patient with mesenteric blood flow mainly supplied by the inferior mesenteric artery; Patient with accessory renal artery original from abdominal artery; Patient who has allergic reaction to the device; Patient who is not suitable for endovascular repair in vascular morphology; Patient who cannot tolerate contrast agents due to renal insufficiency; Patient who is allergic to contrast agent; Patient's aneurysms neck has thrombus; Non-aneurysmal proximal aortic neck length <15mm; Non-aneurysmal proximal aortic neck diameter <18mm or >32mm; Proximal aortic neck angulation > 60°; Distal iliac artery anchorage zone <15mm; Distal iliac artery diameter: i. For Ankura™ AAA and Cuff Stent Graft Systems: <8mm or >22mm, OR ii. For Ankura™ AUI Stent Graft system: <10mm or >16mm
- Patient with hereditary connective tissue disease, including but not limited to Marfan Syndrome or Ehlers-Danlos Syndrome
- Acute myocardial infarction or heart failure (NYHA class III and IV), respiratory failure, malignant tumor and other serious systemic diseases
- Any condition (medical or anatomic) which makes the patient not suitable for endovascular repair according to the opinion of the investigator
- Age<18 years or Age>85 years
- Patients' life expectancy < 1 year
- Pregnant or plan to be pregnant or breast feeding
- Patient with traumatic aortic injury
- Patient with uncorrectable coagulopathy
- Patient who weighs greater than 350 pounds (150kg) or cannot undergo accurate fluoroscopy examination due to obesity
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
3 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The objective of the study is to collect real-world data on patient outcomes and evaluate the safety and performance of the Lifetech Ankura™ AAA Stent Graft System, Ankura™ Cuff Stent Graft System, Ankura™ AUI Stent Graft System and ZoeTrack™ Super Stiff Guidewire.
A vizsgálat csoportja
- AAA Subjects
Patient diagnosed with Abdominal Aortic Aneurysm, who needs endovascular aortic repair.
Kezelés: Ankura™ AAA Stent Graft System; Ankura™ Cuff Stent Graft System; Ankura™ AUI Stent Graft System
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up: A Multi-center, Prospective, Single-arm, Open-label, Post-market Study
- A regiszteradat frissítve
- 2026. május 26.